Header Logo

Connection

Wendy Stevens to HIV

This is a "connection" page, showing publications Wendy Stevens has written about HIV.
Connection Strength

1,428
HIV
  1. Characterization of Lymphomas in a high prevalence HIV setting. J Acquir Immune Defic Syndr. 2010 Apr; 53(5):656-60.
    View in: PubMed
    Score: 0,283
  2. Will etravirine work in patients failing nonnucleoside reverse transcriptase inhibitor-based treatment in southern Africa? J Acquir Immune Defic Syndr. 2009 Dec; 52(5):655-6.
    View in: PubMed
    Score: 0,276
  3. Slow accumulation of HIV resistance mutations: implications for resource-limited settings? J Infect Dis. 2009 Sep 01; 200(5):670-2.
    View in: PubMed
    Score: 0,272
  4. HIV/AIDS prevalence testing--merits, methodology and outcomes of a survey conducted at a large mining organisation in South Africa. S Afr Med J. 2006 Feb; 96(2):134-9.
    View in: PubMed
    Score: 0,212
  5. Automated sequence analysis and editing software for HIV drug resistance testing. J Clin Virol. 2012 May; 54(1):30-5.
    View in: PubMed
    Score: 0,081
  6. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. PLoS Med. 2011 Jul; 8(7):e1001061.
    View in: PubMed
    Score: 0,077
  7. Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? Expert Rev Mol Diagn. 2010 Oct; 10(7):937-46.
    View in: PubMed
    Score: 0,073
  8. Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa. Lancet Infect Dis. 2016 Nov; 16(11):e267-e275.
    View in: PubMed
    Score: 0,028
  9. Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial. J Infect Dis. 2016 Feb 15; 213(4):551-5.
    View in: PubMed
    Score: 0,025
  10. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial. PLoS One. 2013; 8(12):e74900.
    View in: PubMed
    Score: 0,023
  11. Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa. PLoS One. 2013; 8(6):e65421.
    View in: PubMed
    Score: 0,022
  12. Increased microbial translocation in = 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age. Pediatr Infect Dis J. 2011 Oct; 30(10):877-82.
    View in: PubMed
    Score: 0,020
  13. The net cost of incorporating resistance testing into HIV/AIDS treatment in South Africa: a Markov model with primary data. J Int AIDS Soc. 2011 May 15; 14:24.
    View in: PubMed
    Score: 0,019
  14. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood. 2010 Jan 14; 115(2):161-7.
    View in: PubMed
    Score: 0,017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.